Arkolith/Insider Trading/IMGO/Form 4

Rienhoff Hugh JR

Chief Executive Officer, DirectorImago BioSciences, Inc. (IMGO) · full profile →Form 4 · filed Dec 19, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16.9M
Net Open-Market Flow
-$16.9M
Transactions
14
8 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 16, 2022Sell(S)267K$35.78$9.5M490K
Dec 16, 2022Option exercise(M)37K$2.10$79K611K
Dec 16, 2022Option exercise(M)84K$1.52$128K574K
Dec 16, 2022Option exercise(M)145K$2.52$365K756K
Dec 15, 2022Option exercise(M)102K$2.52$258K649K
Dec 15, 2022Sell(S)206K$35.80$7.4M490K
Dec 15, 2022Option exercise(M)47K$1.52$71K696K
Dec 15, 2022Option exercise(M)57K$2.10$121K547K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2022Option exercise(M)37K—$062K
Dec 16, 2022Option exercise(M)145K—$07K
Dec 16, 2022Option exercise(M)84K—$012K
Dec 15, 2022Option exercise(M)102K—$0152K
Dec 15, 2022Option exercise(M)47K—$096K
Dec 15, 2022Option exercise(M)57K—$0100K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-021786) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML